Stock Updates

Gilead Sciences Inc. (NASDAQ: GILD) – Is this large market cap stock undervalued?

Gilead Sciences Inc. (NASDAQ: GILD), is firmly in the large market cap category with market cap of 104213.55. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Gilead Sciences Inc. is 78.97 (with a change from open of -0.19%), this in conjunction with a target price of 104.5. Volume today has so far reached 6836400, with an average volume of about 10527.47. The GAP for this stock, is -0.16%.

The P/E ratio is 6.96, bringing the forward P/E to a value of 6.8. The current EPS for Gilead Sciences Inc., is 11.35, with a EPS growth for this year coming to a value of 62.00%. Performance has been interesting with performance year to date coming to -20.66%.

Looking further into the growth statistics for Gilead Sciences Inc., EPS is looking like it will grow -1.17% in the next year. Looking even further it is projected to be -0.21%. Quarter over quarter is -11.50% for EPS growth and for sales growth quarter over quarter it is -5.70%. Looking at past EPS growth statistics we see that for the past five years it has been 48.30%. Sales growth for the past five years has in fact been 32.60%.

Looking at the ownership, we see that the insider ownership is at 0.40% and institutional ownership is 80.50%. Shares outstanding is 1319.66, while shares float is at a value of 1311.57. Float short for Gilead Sciences Inc. is 1.23% and the short ratio is 1.53.

In terms of debt, long term debt/equity is 1.38, while the total debt/equity comes to 1.42. The ability to meet these debts, means that the current ratio is 1.8, and the quick ratio is 1.6. The most recent gross margin is 87.10% and their operating margin is 63.00%. The profit margin is 50.50%.

Gilead Sciences Inc. has seen returns on assets of 32.70%, and on investment, 45.90%. Return on equity is 100.80%. Price/Earnings to growth ratio is *TBA. Price/Sales ratio is at a value of 3.22, with Price/book ratio coming to 6.78 and Price/cash is 11.91, and finally Price/Free cash Flow is 7.17.

The simple moving averages are -1.27% and -9.13% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -27.43% and the 52 week low is 3.62%.

Gilead Sciences Inc. has a dividend yield of 2.38%, with a current price of 78.97. The ability to pay this means the payout ratio is 15.20%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Gilead Sciences Inc. is based in USA.

Performance in the Biotechnology industry means that Gilead Sciences Inc. has seen performance for the past week of -3.34%, with performance for the month coming to 1.64%. Looking at the data for the quarter it is at a value of -3.43%, and for the half year the performance is -16.01%. Volatility for this week is 1.34% and for the month this is 1.51%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment